Search Constraints
« Previous |
1 - 10 of 19
|
Next »
Search Results
Select an image to start the slideshow
Noradrenergic dysfunction in neurodegenerative disease
1 of 10
The Effects of Chronic, Oral Deltamethrin Exposure on Nigrostriatal Dopamine Receptors: A Model for Pyrethroid Toxicity in Adults
2 of 10
Cannabinoid type 2 receptors regulate striatal inflammation following alpha synuclein-induced nigral degeneration in rat model of Parkinson’s disease
3 of 10
Innate and Adaptive Immune System Crosstalk in Parkinson's Disease
4 of 10
Ultrastructural Plasticity of Pallidothalamic GABAergic Terminals in Parkinson’s Disease: A 3D Electron Microscopy Study in the Parvocellular Ventral Anterior and Centromedian Thalamic Nuclei in MPTP-Treated Parkinsonian Monkeys
5 of 10
LRRK2 and Environmental Effects on Dopamine Systems within the Gut-Brain Axis: A Parkinson’s Disease Pathology Focus
6 of 10
Abnormal muscle activity during balance before and after an exercise-based balance rehabilitation in people with Parkinson’s disease
7 of 10
Gene-Environment Interplay in Parkinson’s Disease Pathogenesis: The Role of Gastrointestinal Inflammation and Regulator of G-protein Signaling 10 in the Gut-Brain Axis
8 of 10
The impact of LRRK2 expression and kinase activity in gene by environment mouse models of Parkinson’s disease
9 of 10
Synaptic Vesicle Glycoprotein 2C (SV2C) in Parkinson's Disease-Related Striatal Vesicular Dysfunction
10 of 10